Cargando…
Treatment of Acute Tacrolimus Toxicity with Phenytoin in Solid Organ Transplant Recipients
The pharmacokinetics of tacrolimus are influenced by many factors, including genetic variability, acute infections, liver dysfunction, and interacting medications, which can result in elevated concentrations. The most appropriate management of acute tacrolimus toxicity has not been defined though ca...
Autores principales: | Jantz, Arin S., Patel, Samir J., Suki, Wadi N., Knight, Richard J., Bhimaraj, Arvind, Gaber, A. Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697147/ https://www.ncbi.nlm.nih.gov/pubmed/23844312 http://dx.doi.org/10.1155/2013/375263 |
Ejemplares similares
-
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
por: Kwon, Eun-Jeong, et al.
Publicado: (2022) -
Phenytoin and Rifampin Do Not Decrease Levels in Acute Tacrolimus Toxicity
por: Lawson, Benjamin O., et al.
Publicado: (2018) -
Kidney Donors With Diabetes: Renal Biopsy Findings at Time of Transplantation and Their Significance
por: Truong, Luan D., et al.
Publicado: (2019) -
Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
por: Marfo, Kwaku, et al.
Publicado: (2010) -
Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients
por: Gaber, A. Osama, et al.
Publicado: (2013)